These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4560914)

  • 41. Sensitivity studies on Serratia strains from clinical specimens.
    von Graevenitz A
    Chemotherapy; 1967; 12(4):215-25. PubMed ID: 4863818
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacterial resistance to penicillins and cephalosporins.
    Smith JT; Hamilton-Miller JM; Knox R
    J Pharm Pharmacol; 1969 Jun; 21(6):337-58. PubMed ID: 4389168
    [No Abstract]   [Full Text] [Related]  

  • 43. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.
    Finland M; McGowan JE; Garner C; Wilcox C
    J Infect Dis; 1974 Jun; 129(0):suppl:S132-8. PubMed ID: 4210005
    [No Abstract]   [Full Text] [Related]  

  • 45. Soil bacteriostasis limitation in growth of soil and rhizosphere bacteria.
    Brown ME
    Can J Microbiol; 1973 Feb; 19(2):195-9. PubMed ID: 4572375
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
    Piccolomini R; Di Sipio L; Ravagnan G
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibacterial activity of cephalothin].
    Goto S; Kuwabara S
    J Antibiot B; 1965 Dec; 18(6):439-42. PubMed ID: 5296406
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the clinical aspects of cephalosporins. I. Bacteriological section].
    Breitfellner G
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):174-9. PubMed ID: 4895448
    [No Abstract]   [Full Text] [Related]  

  • 49. Physical compatibility and chemical stability of cephapirin sodium in combination with antibiotics and large-volume parenteral solutions. I.
    Prasad VK; Granatek AP; Mihotic MM
    Curr Ther Res Clin Exp; 1974 May; 16(0):505-39. PubMed ID: 4365711
    [No Abstract]   [Full Text] [Related]  

  • 50. The action of cephaloridine with cloxacillin or methicillin against beta-lactamase-producing gram-negative bacteria.
    O'Callaghan CH; Muggleton PW
    J Gen Microbiol; 1967 Sep; 48(3):449-60. PubMed ID: 4964029
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P
    Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
    [No Abstract]   [Full Text] [Related]  

  • 52. Aspects of the mechanism of action of some cephalosporins.
    Russell AD; Fountain RH
    J Bacteriol; 1971 Apr; 106(1):65-9. PubMed ID: 4928017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.
    Dale JW
    Biochem J; 1971 Jul; 123(4):501-5. PubMed ID: 4942447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.
    Finland M
    Ann Intern Med; 1972 Jun; 76(6):1009-36. PubMed ID: 4402139
    [No Abstract]   [Full Text] [Related]  

  • 55. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 56. Penicillin acylase (bacterial).
    Savidge TA; Cole M
    Methods Enzymol; 1975; 43():705-21. PubMed ID: 237220
    [No Abstract]   [Full Text] [Related]  

  • 57. Biosynthesis of benzylpenicillin acylase by Escherichia coli NCIM-2400.
    Sudhakaran VK; Borkar PS
    Hindustan Antibiot Bull; 1989; 31(1-2):1-14. PubMed ID: 2693412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of cefazolin against recent clinical bacterial isolates.
    Sabath LD; Wilcox C; Garner C; Finland M
    J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics of cefazolin compared with four other cephalosporins.
    Kirby WM; Regamey C
    J Infect Dis; 1973 Oct; 128():Suppl:S341-6. PubMed ID: 4744015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.